<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="this virus might have evolved from the bat coronavirus. The" exact="infection" post="by this virus started in Hubei, in the city"/>
 <result pre="levels and elevated serum bilirubin levels [24]. The direct viral" exact="infection" post="of liver cell may be the cause of liver"/>
 <result pre="increased AST level, prothrombin time prolongation and hypoproteinemia. The direct" exact="infection" post="of the liver was confirmed by the existence of"/>
 <result pre="with COVID-19 also showed steatosis and liver injury [30]. The" exact="infection" post="with COVID-19 and the development of the disease are"/>
 <result pre="high levels of inflammatory cytokines and of biomarkers related to" exact="infection" post="and the number of T lymphocytes CD3+ and CD4+"/>
 <result pre="sustained within the normal levels in patients with SARS-CoV-2 non-complicated" exact="infection" post="and its elevation may indicate bacterial co-infection in patients"/>
 <result pre="is commonly induced in a septic shock environment [45]. Therefore," exact="treatment" post="with antioxidants can be a way to bypass the"/>
 <result pre="on the outcome of the patient. A delay in the" exact="diagnosis" post="may also alter the effect of the drugs. Moreover,"/>
 <result pre="nowadays employed against autoimmune disease and in the prophylaxis and" exact="treatment" post="of malaria. These drugs also suppress the replication of"/>
 <result pre="in tissues, such as the lung [47]. Chloroquine blocks viral" exact="infection" post="by alkalinizing the endosomal pH in the phagolysosome and"/>
 <result pre="300 mg/2 days on days 2â€&quot;5 days and finishing the" exact="treatment" post="at day 5 to decrease the risk of side"/>
 <result pre="high doses for long periods [56]. In the present global" exact="infection" post="of SARS-CoV-2, treatment with hydroxychloroquine combined with azithromycin, a"/>
 <result pre="long periods [56]. In the present global infection of SARS-CoV-2," exact="treatment" post="with hydroxychloroquine combined with azithromycin, a macrolide antibiotic, resulted"/>
 <result pre="by SARS-CoV-2. Chloroquine has also been proposed as a preventative" exact="treatment" post="for COVID-19 [57]. In that study the authors gave"/>
 <result pre="may be due to other factors that are associated with" exact="treatment" post="in addition to the infection by the virus. Therefore,"/>
 <result pre="factors that are associated with treatment in addition to the" exact="infection" post="by the virus. Therefore, doses and interactions of medications"/>
 <result pre="properties and to monitor and analyze the ECG during the" exact="treatment" post="[58]. This is further emphasized by the reported studies"/>
 <result pre="Preliminary findings in a total of 499 patients that received" exact="treatment" post="with Remdesivir against the disease of EBOV showed a"/>
 <result pre="452 hospitalized adult subjects with severe COVID-19 [64]. In the" exact="treatment" post="of SARS-CoV-2, antivirals which include oseltamivir, lopinavir/ritonavir, ganciclovir and"/>
 <result pre="in patients with SARS-CoV-2 in combination with other therapeutics. Combination" exact="treatment" post="of low-dose systematic corticosteroids and antivirals and atomized inhalation"/>
 <result pre="efficiency. Most patients in septic shock trials also show bacterial" exact="infection" post="that results in myocardial insufficiency and vasoplegic shock. However,"/>
 <result pre="the filling of the heart and not vasoplegia. Therefore, the" exact="treatment" post="using corticosteroid should not be employed for lung injury"/>
 <result pre="It has little side effects and is approved for SARS" exact="treatment" post="[69]. Arbidol or ethyl-6-bromo-4-I(dimethylamino)methyl-hydroxy1-methyl-2((phenylthio)methyl)-indoe-3 carboxylate hydrochloride monohydrate, is a"/>
 <result pre="arbidol has been employed in China since 2006 for the" exact="treatment" post="and prophylaxis of human pulmonary diseases caused by influenza"/>
 <result pre="arbidol and carrimycin and its efficacy against the novel coronavirus" exact="infection" post="has been informed. Therefore, its use has been widely"/>
 <result pre="proposed ([73] ClinicalTrials.gov. Identifier NCT04275388). Currently several trials compare lopinavir-ritonavir" exact="treatment" post="and other drugs for COVID-19â€&quot;versus ARB ([74] ClinicalTrials.gov, Identifier"/>
 <result pre="rate when there is cardiac injury associated to a viral" exact="infection" post="as reported in previous studies ([76] ClinicalTrials.gov, Identifier NCT04291729)."/>
 <result pre="blood sugar concentration. In addition, as has been seen after" exact="treatment" post="with an HIV treatment, conditions may change in the"/>
 <result pre="the patients. It has also been reported that the COVID-19" exact="infection" post="leads to a higher mortality rate in elderly patients."/>
 <result pre="conditions might be prostatic growth. Patients with prostatic growth receive" exact="treatment" post="with alfuzosine, which, when combined with ritonavir, predisposes to"/>
 <result pre="arrhythmias or other adverse reactions of drugs used for the" exact="treatment" post="of COVID-19. The use of antipsychotics and neuroleptics is"/>
 <result pre="of antioxidant therapy as a complementary measure to the pharmacological" exact="treatment" post="of COVID-19 where sepsis is present. Although anti-oxidant therapy"/>
 <result pre="one or more of the following antioxidant compounds for the" exact="treatment" post="of COVID-19. 11. N-acetylcysteine Preclinical studies have proposed the"/>
 <result pre="activity and has a direct action on free radicals. However," exact="treatment" post="with NAC does not decrease lung tissue myeloperoxidase activity"/>
 <result pre="biomarkers of inflammation in patients with septic shock and NAC" exact="treatment" post="in a double-blind, placebo-controlled clinical trials have been evaluated."/>
 <result pre="clinical trials have been evaluated. The results showed that NAC" exact="treatment" post="improved oxygenation, static lung compliance, decreased levels of IL-8"/>
 <result pre="authors reported an increase in mortality in patients that received" exact="treatment" post="after 24 h of hospital admission [98]. The NAC"/>
 <result pre="(17.9 Â± 24 ÂµM). Plasma levels increased dramatically in both" exact="treatment" post="groups. No adverse effects were reported in the patients"/>
 <result pre="the cell membrane and maintaining an adequate immune response to" exact="infection" post="[114]. We believe that the combined treatment with vitamin"/>
 <result pre="immune response to infection [114]. We believe that the combined" exact="treatment" post="with vitamin E and C is a very promising"/>
 <result pre="in the conclusion that pentoxifylline may be a beneficial adjuvant" exact="treatment" post="in sepsis [136] and could also be used in"/>
 <result pre="the effects of the antioxidants on the patients by SARS-Cov-2" exact="infection" post="addressed in the manuscript. Proposal of Therapeutic Management with"/>
 <result pre="of Therapeutic Management with Antioxidants The design of the study" exact="testing" post="the usefulness of antioxidants as an adjuvant in the"/>
 <result pre="testing the usefulness of antioxidants as an adjuvant in the" exact="treatment" post="of COVID-19 must be non-randomized regarding the use of"/>
 <result pre="receptor for SARS-CoV-2 in all target organs. The mechanism of" exact="infection" post="by the virus correlates with the comorbidities that increase"/>
 <result pre="with the comorbidities that increase the death rate of the" exact="infection" post="since the ACE2 receptor number is altered by the"/>
 <result pre="coronavirus particleAdv. Virus Res.20169612727712621 4.QuC.ZhangS.LiY.WangY.PeppelenboschM.P.PanQ.Mitochondria in the biology, pathogenesis and" exact="treatment" post="of hepatitis virus infectionsRev. Med. Virol.201929207510.1002/rmv.2075 5.MondalS.P.CardonaC.MicrobiologÃ­a VeterinariaStanchiN.O.Inter-MÃ©dicaBuenos Aires,"/>
 <result pre="Hepatol.202010.1016/j.jhep.2020.06.006 27.HuL.L.WangW.J.ZhuQ.J.YangL.Novel coronavirus pneumonia related liver injury: Etiological analysis and" exact="treatment" post="strategyZhonghua Gan Zang Bing Za Zhi202028132023688 28.TimensW.BulthuisM.L.C.LelyA.T.NavisG.J.van GoorH.Tissue distribution"/>
 <result pre="acidification by chloroquine analogs as a promising strategy for the" exact="treatment" post="of emerging viral diseasesPharmacol. Res. Perspec.201750029310.1002/prp2.293 50.RoutyJ.P.AngelJ.B.PatelM.KanagarathamC.RadziochD.KemaI.GilmoreN.AncutaP.SingerJ.JenabianM.A.Assessment of chloroquine"/>
 <result pre="review on the efficacy and safety of chloroquine for the" exact="treatment" post="of COVID-19J. Crit. Care20205727928310.1016/j.jcrc.2020.03.00532173110 54.ColsonP.RolainJ.M.LagierJ.C.BrouquiP.RaoultD.Chloroquine and hydroxychloroquine as available"/>
 <result pre="or hydroxychloroquineInt. J. Antimicrob. Agents20205510594510.1016/j.ijantimicag.2020.10594532194152 58.GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraV.E.Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: Results of an open-label non-randomized clinical trialInt."/>
 <result pre="related to anti-malarials in systemic lupus erythematosusClin. Exp. Rheumatol.20183654555129652656 61.ZuoX.MengF.WuF.ZhaoX.LiC.ChengG.QinF.X.Combinatorial" exact="screening" post="of a panel of FDA-approved drugs identifies several candidates"/>
 <result pre="for new challengesCrit. Care2020249110.1186/s13054-020-2818-632178711 68.RussellC.D.MillarJ.E.BaillieJ.K.Clinical evidence does not support corticosteroid" exact="treatment" post="for 2019-nCoV lung injuryLancet202039547347510.1016/S0140-6736(20)30317-232043983 69.BlaisingJ.PolyakS.J.PÃ©cheurE.I.Arbidol as a broad-spectrum antiviral:"/>
 <result pre="chebula in diabetic rats. AvicennaJ. Phytomed.20199454464 83.TaraziR.C.Sympathomimetic agents in the" exact="treatment" post="of shockAnn. Intern. Med.19748136437110.7326/0003-4819-81-3-3644605195 84.ChalupskyK.LobyshevaI.NepveuF.GadeaI.BeranovaP.EntlicherG.StocletJ.C.MullerB.Relaxant effect of oxime derivatives"/>
 <result pre="Care2003926627010.1097/00075198-200308000-0000312883280 88.GalvÃ£oA.M.de AndradeA.D.de Souza MaiaM.B.Ramos da SilvaK.E.BezerraA.MeloJ.F.MoraisN.G.CostaT.B.CastroC.M.Antioxidant supplementation for the" exact="treatment" post="of acute lung injury: A meta-analysisRev. Bras. Ter. Intensiva201123414810.1590/S0103-507X201100010000825299553"/>
 <result pre="acid-induced lung injuryPulm. Pharmacol. Ther.20041726327010.1016/j.pupt.2004.05.00215477121 93.SciutoA.M.StricklandP.T.KennedyT.P.GurtnerG.H.Protective effects of N acetylcysteine" exact="treatment" post="after phosgene exposure in rabbitsAm. J. Respir. Crit. Care"/>
 <result pre="N-acetyl-L-cysteine influence cytokine response during early human septic shockChest19981131616162410.1378/chest.113.6.16169631802 99.MolnÃ¡rZ.ShearerE.LoweD.N-Acetylcysteine" exact="treatment" post="to prevent the progression of multisystem organ failure: A"/>
 <result pre="J.20153414314810.1097/INF.0000000000000698 135.AkdagA.DilmenU.HaqueK.DilliD.ErdeveO.GoekmenT.Role of IgM-enriched intravenous pentoxifylline and/or immunoglobulin in the" exact="treatment" post="of neonatal sepsisAm. J. Perinatol.20143190591210.1055/s-0033-136377124515621 136.PammiM.HaqueK.N.Pentoxifylline for the treatment"/>
 <result pre="the treatment of neonatal sepsisAm. J. Perinatol.20143190591210.1055/s-0033-136377124515621 136.PammiM.HaqueK.N.Pentoxifylline for the" exact="treatment" post="of sepsis and necrotizing enterocolitis in neonatesCochrane Database Syst."/>
 <result pre="outcomes in severe cases. Ñ² The lung inflammation [67,68,69]. The" exact="treatment" post="using corticosteroid should not be employed for lung injury"/>
 <result pre="clinical effect, that is propose as adjuvant therapy for the" exact="treatment" post="of patients infected with COVID-19. Treatment Antioxidant Effect Clinical"/>
 <result pre="Antibiotics, according to requirements. A culture if an associated bacterial" exact="infection" post="is present. 2. Mechanical ventilation. 3. Hemodynamic Management. 4."/>
 <result pre="+ PentoxifyllineOn Dialysis or HemodialysisStandard dose. Immunoglobulin should be the" exact="treatment" post="of choice except contraindication ArrhythmiasNAC or MT or QRC"/>
</results>
